Chung Robert T, Cheung Yvonne Y, Henderson Eric R, Linos Konstantinos, Kerr Darcy A
Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Department of Radiology, Dartmouth-Hitchcock Medical Center, NH, Lebanon.
Int J Surg Pathol. 2023 Jun;31(4):419-426. doi: 10.1177/10668969221102560. Epub 2022 Jun 1.
Hemangioblastoma, one of the characteristic tumors associated with Von Hippel-Lindau (VHL) disease, most often presents in the central nervous system (CNS) but can uncommonly arise in extraneuraxial, or previously referred to as peripheral, locations. Without the clinical context of known VHL disease, hemangioblastoma may not enter the differential for a soft tissue mass outside the CNS. Here, we present two patients with diagnostically challenging extraneuraxial hemangioblastoma to highlight the importance of considering this entity within the differential diagnosis of soft tissue neoplasms containing clear cells and delicate vasculature. We review the relevant diagnostic features, including a suggested immunohistochemical panel, along with the potential associated clinical implications of making this diagnosis. It is recommended that affected patients be offered genetic counseling to assess for underlying VHL disease.
血管母细胞瘤是与冯·希佩尔-林道(VHL)病相关的特征性肿瘤之一,最常出现在中枢神经系统(CNS),但也可能罕见地发生在神经轴外部位,或以前称为外周的部位。在没有已知VHL病的临床背景下,血管母细胞瘤可能不会被列入中枢神经系统外软组织肿块的鉴别诊断中。在此,我们报告两例诊断具有挑战性的神经轴外血管母细胞瘤患者,以强调在含有透明细胞和纤细脉管系统的软组织肿瘤鉴别诊断中考虑这一实体的重要性。我们回顾了相关的诊断特征,包括建议的免疫组织化学检测组合,以及做出该诊断可能相关的临床意义。建议为受影响的患者提供遗传咨询,以评估是否存在潜在的VHL病。